Genetic testing in a population-based sample of breast and ovarian cancer survivors from the REACH randomized trial: Cost barriers and moderators of counseling mode
Cancer Epidemiology, Biomarkers & Prevention Oct 06, 2017
Steffen LE, et al. - In this study, predictors of BRCA1/2 testing were assessed among breast and ovarian cancer survivors who received genetic counseling as part of a randomized trial and moderators of counseling mode on testing uptake were determined. Researchers recognized cost concerns as a strong determinant of testing. Pre-counseling distress and risk perceptions seemed to influence the differences in testing uptake by counseling mode. In population-based samples of at risk cancer survivors, cost concerns could contribute to low testing. They recommended considering pre-counseling psychosocial characteristics when offering in-person vs. telephone counseling.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries